Literature DB >> 9777940

Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization.

A K Walch1, H F Zitzelsberger, M M Aubele, A E Mattis, M Bauchinger, S Candidus, H W Präuer, M Werner, H Höfler.   

Abstract

Neuroendocrine tumors of the lung represent a wide spectrum of phenotypically distinct entities with different biological characteristics such as typical carcinoid tumor (TC), atypical carcinoid tumor (AC), large-cell neuroendocrine carcinoma (LCNEC), and small-cell lung carcinoma (SCLC). The histogenetic relationships between TC, AC, LCNEC, and SCLC are still unclear. This study was carried out to provide cytogenetic data about pulmonary neuroendocrine tumors and to evaluate their characteristic alterations and histogenetic relations for an improved understanding of the mechanisms of tumor development. Twenty-nine paraffin-embedded tumor samples of TC (n = 17), AC (n = 6), LCNEC (n = 3), and SCLC (n = 3) were selected for isolation of tumor DNA and subsequent comparative genomic hybridization (CGH) analysis. To confirm the comparative genomic hybridization results for characteristic chromosomal imbalances, selected cases were additionally investigated by loss of heterozygosity analysis. For statistical evaluation, we also used comparative genomic hybridization data from 45 published SCLC cases. DNA underrepresentations of 11q were the most frequent findings in TC (8 of 17) and AC (4 of 6), whereas these aberrations were rare in LCNEC (1 of 3) and SCLC (0 of 3). Furthermore, AC showed DNA underrepresentation of 10q (3 of 6) and 13q (3 of 6). In contrast, SCLC and LCNEC were characterized by a different pattern of DNA losses (3p-, 4q-, 5q-, 13q-, and 15q-) and gains (5p+, 17p+, and +20). Statistical analysis revealed significantly different occurrences of 11q deletions in TC/AC versus SCLC (45 published cases of SCLC and our 3 cases; P = 0.002; Fisher's exact test). Thus, TC and AC display frequent loss of 11q material including the MEN1 gene locus, which represents a characteristic genetic alteration in these tumors. Losses of 10q and 13q sequences allow a further cytogenetic differentiation between TC and AC. These additional changes might be responsible for the more aggressive behavior of AC. Three cases of LCNEC, the first to be analyzed by comparative genomic hybridization, exhibited similar complex abnormal patterns (4q-, 5q-, 10q-, 13q-, 15q-) to those of SCLC. Although neuroendocrine tumors of the lung share common phenotypic features, suggesting a genotypic relationship, they differ remarkably in their cytogenetic characteristics, highlighting an early fundamental molecular divergence during the development of these tumors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9777940      PMCID: PMC1853037          DOI: 10.1016/S0002-9440(10)65653-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  54 in total

1.  Well differentiated and small cell neuroendocrine carcinomas of the lung. Two related but distinct clinicopathologic entities.

Authors:  W H Warren; V A Memoli; V E Gould
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1988

Review 2.  Comparative genomic hybridisation for the analysis of chromosomal imbalances in solid tumours and haematological malignancies.

Authors:  H Zitzelsberger; L Lehmann; M Werner; M Bauchinger
Journal:  Histochem Cell Biol       Date:  1997 Oct-Nov       Impact factor: 4.304

3.  Reproducibility of neuroendocrine lung tumor classification.

Authors:  W D Travis; A A Gal; T V Colby; D S Klimstra; R Falk; M N Koss
Journal:  Hum Pathol       Date:  1998-03       Impact factor: 3.466

4.  Immunohistochemical and ultrastructural analysis of bronchopulmonary neuroendocrine neoplasms. I. Carcinoids.

Authors:  W H Warren; V A Memoli; V E Gould
Journal:  Ultrastruct Pathol       Date:  1984       Impact factor: 1.094

5.  Trisomy 7 in a lung carcinoid tumor: precocious index of malignant transformation?

Authors:  J R Teyssier; R Sadrin; J M Nou; G Bureau; J J Adnet; F Bajolle; F Pigeon
Journal:  Cancer Genet Cytogenet       Date:  1985-02-15

6.  Immunohistochemical and ultrastructural analysis of bronchopulmonary neuroendocrine neoplasms. II. Well-differentiated neuroendocrine carcinomas.

Authors:  W H Warren; V A Memoli; V E Gould
Journal:  Ultrastruct Pathol       Date:  1984       Impact factor: 1.094

Review 7.  Neuroendocrine components of the bronchopulmonary tract: hyperplasias, dysplasias, and neoplasms.

Authors:  V E Gould; R I Linnoila; V A Memoli; W H Warren
Journal:  Lab Invest       Date:  1983-11       Impact factor: 5.662

8.  Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23).

Authors:  J Whang-Peng; C S Kao-Shan; E C Lee; P A Bunn; D N Carney; A F Gazdar; J D Minna
Journal:  Science       Date:  1982-01-08       Impact factor: 47.728

9.  Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma.

Authors:  C Larsson; B Skogseid; K Oberg; Y Nakamura; M Nordenskjöld
Journal:  Nature       Date:  1988-03-03       Impact factor: 49.962

10.  Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung.

Authors:  J Yokota; M Wada; Y Shimosato; M Terada; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

View more
  24 in total

1.  11q13 allelic imbalance discriminates pulmonary carcinoids from tumorlets. A microdissection-based genotyping approach useful in clinical practice.

Authors:  S D Finkelstein; T Hasegawa; T Colby; S A Yousem
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

2.  The Art and Applications of Fluorescence In Situ Hybridization in Endocrine Pathology.

Authors:  George Kontogeorgos
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

3.  A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers.

Authors:  Sana Yokoi; Kohichiroh Yasui; Fumiko Saito-Ohara; Katsumi Koshikawa; Toshihiko Iizasa; Takehiko Fujisawa; Takeo Terasaki; Akira Horii; Takashi Takahashi; Setsuo Hirohashi; Johji Inazawa
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

4.  Chromosomal instability is more frequent in metastasized than in non-metastasized pulmonary carcinoids but is not a reliable predictor of metastatic potential.

Authors:  Arne Warth; Esther Herpel; Sabine Krysa; Hans Hoffmann; Philipp A Schnabel; Peter Schirmacher; Gunhild Mechtersheimer; Hendrik Bläker
Journal:  Exp Mol Med       Date:  2009-05-31       Impact factor: 8.718

Review 5.  Neuroendocrine tumors of the thymus and mediastinum.

Authors:  Hanibal Bohnenberger; Helen Dinter; Alexander König; Philipp Ströbel
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

6.  Deletions of 11q22.3-q25 are associated with atypical lung carcinoids and poor clinical outcome.

Authors:  Dorian R A Swarts; Sandra M H Claessen; Yvonne M H Jonkers; Robert-Jan van Suylen; Anne-Marie C Dingemans; Wouter W de Herder; Ronald R de Krijger; Egbert F Smit; Frederik B J M Thunnissen; Cornelis A Seldenrijk; Aryan Vink; Aurel Perren; Frans C S Ramaekers; Ernst-Jan M Speel
Journal:  Am J Pathol       Date:  2011-07-16       Impact factor: 4.307

7.  Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumors.

Authors:  Johannes Voortman; Jih-Hsiang Lee; Jonathan Keith Killian; Miia Suuriniemi; Yonghong Wang; Marco Lucchi; William I Smith; Paul Meltzer; Yisong Wang; Giuseppe Giaccone
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-06       Impact factor: 11.205

Review 8.  [Neuroendocrine tumors of the lung].

Authors:  K-M Müller
Journal:  Pathologe       Date:  2003-05-29       Impact factor: 1.011

9.  [CGH findings in neuroendocrine tumours of the lung].

Authors:  G Johnen; M Krismann; M Jaworska; K-M Müller
Journal:  Pathologe       Date:  2003-05-15       Impact factor: 1.011

10.  Common Diagnostic Challenges in the Histopathologic Diagnosis of Neuroendocrine Lung Tumors: A Case Report.

Authors:  Monica Valente; Laura Catena; Massimo Milione; Sara Pusceddu; Barbara Formisano; Emilio Bajetta
Journal:  Case Rep Oncol       Date:  2010-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.